Emtricitabine 200mg and tafero tablets uses,dosage,composition,side-effects- TAFERO EM
Tafero EM is a combination antiretroviral medicine that contains Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg. It is widely used in the management and prevention of Human Immunodeficiency Virus (HIV) infection. This medication works by inhibiting viral replication, thereby reducing the viral load in the body and helping the immune system function more effectively. Tafero tablets are prescribed for HIV-1 treatment as part of combination therapy and are also used for pre-exposure prophylaxis (PrEP) in individuals at high risk of HIV infection, under medical supervision.
The usual dosage of Tafero tablets depends on the patient’s clinical condition, age, kidney function, and whether it is used for treatment or prevention. Typically, it is taken once daily with or without food, as advised by a healthcare professional. It is important not to miss doses, as irregular intake can reduce effectiveness and increase the risk of drug resistance. The composition of Tafero EM ensures better drug delivery with lower systemic exposure, which helps minimize long-term toxicity compared to older formulations.
Common side effects may include nausea, headache, fatigue, dizziness, and mild gastrointestinal discomfort. These effects are generally temporary and improve as the body adjusts to the medicine. Serious side effects are rare but may include kidney issues, bone density changes, or liver-related problems, especially in patients with existing conditions. Precautions are necessary for individuals with kidney disease, liver disorders, hepatitis B infection, or osteoporosis. Regular medical monitoring is recommended during treatment.
Tafero tablets may interact with certain antiviral drugs, anticonvulsants, antibiotics, and herbal supplements, which can affect drug levels in the body. Informing the doctor about all current medications is essential. Substitutes for Tafero EM include other Emtricitabine and Tenofovir-based combinations, depending on medical suitability. Review